Trials / Completed
CompletedNCT00038636
A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 36 (planned)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the safety and effectiveness of a high dose of ABT-378/ritonavir
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lopinavir/ritonavir | |
| DRUG | Ritonavir |
Timeline
- Start date
- 2000-09-01
- First posted
- 2002-06-04
- Last updated
- 2006-08-15
Locations
7 sites across 3 countries: United States, France, Spain
Source: ClinicalTrials.gov record NCT00038636. Inclusion in this directory is not an endorsement.